Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Hay

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|February 7, 2004
Volunteer counsellors for supporting breast feeding: support for breast feeding must be proactiveAnnette E Hay
Hematology/Oncology Clinics of North America|November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy aloneAnnette E Hay, Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectivenessAnnette E Hay, Ralph M Meyer
Journal of Medical Economics|February 13, 2019
CAR T-cells: costs, comparisons, and commentaryAnnette E Hay, Matthew C Cheung
Haematologica|November 9, 2004
Latency of onset of de novo myelodysplastic syndromesPei-shan Wu, Annette E Hay, Giles E Thomas, et al.
BMC Medical Research Methodology|August 3, 2023
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials GroupLouis Everest, Bingshu E Chen, Annette E Hay, et al.
BMJ Open|August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunitiesBrooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Canadian Journal of Diabetes|January 11, 2024
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort StudySarah Moore-Vasram, Monakshi Sawhney, Robyn L Houlden, et al.
Leukemia & Lymphoma|July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trialAbi Vijenthira, Xinzhi Li, Michael Crump, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
People Living with HIV Eligibility in Canadian Cancer Clinical TrialsMaria F Comelles, Santiago Perez-Patrigeon, Tessa Senneker, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|February 7, 2004
Volunteer counsellors for supporting breast feeding: support for breast feeding must be proactiveAnnette E Hay
Hematology/Oncology Clinics of North America|November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy aloneAnnette E Hay, Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectivenessAnnette E Hay, Ralph M Meyer
Journal of Medical Economics|February 13, 2019
CAR T-cells: costs, comparisons, and commentaryAnnette E Hay, Matthew C Cheung
Haematologica|November 9, 2004
Latency of onset of de novo myelodysplastic syndromesPei-shan Wu, Annette E Hay, Giles E Thomas, et al.
BMC Medical Research Methodology|August 3, 2023
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials GroupLouis Everest, Bingshu E Chen, Annette E Hay, et al.
BMJ Open|August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunitiesBrooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Canadian Journal of Diabetes|January 11, 2024
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort StudySarah Moore-Vasram, Monakshi Sawhney, Robyn L Houlden, et al.
Leukemia & Lymphoma|July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trialAbi Vijenthira, Xinzhi Li, Michael Crump, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
People Living with HIV Eligibility in Canadian Cancer Clinical TrialsMaria F Comelles, Santiago Perez-Patrigeon, Tessa Senneker, et al.
Pageof 6